Episode Details
Back to EpisodesCOVID-19 clinical update #103 with Dr. Daniel Griffin
Episode 870
Published 3 years, 10 months ago
Description
In COVID-19 clinical update #102, Daniel Griffin covers immunocompromised people, hospitalization of children, vaccine usage update, Omicron and cross-reactive neutralizing antibodies, reinfection prevents disease in hamsters, repeated infections with endemic coronaviruses, global burden of antimicrobial resistance, ivermectin not protective in hamsters, and Omicron evades therapeutic monoclonals.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- What does society owe immunocompromised people (Atlantic)
- Prevalence of immunosuppression in US (JAME)
- Hospitalizations of children (MMWR)
- Clinical considerations for vaccines (CDC)
- Sanofi seeks vaccine approval (Sanofi)
- Omicron triggers cross-reactive neutralization (medRxiv)
- Reinfection prevents disease in hamsters (Cell)
- Repeated infections with endemic CoV (J Inf Dis)
- Global burden of antimicrobial resistance (Lancet)
- Ivermectin not protective in hamsters (bioRxiv)
- Omicron evades therapeutic monoclonals (bioRxiv)
- Letters read on TWiV 870
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv